Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MGY vs GSK✓SelectedUSD · GSKMGY vs GSK performance historyLatest closeAs of-2.15%11/18
Stock and ETF performance explorer

MGY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-21.1%
GSK return
-0.7%
Excess return
-20.4%
Maximum drawdown
-24.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.1%-1.3%-0.8%-2.4%
7D-2.3%-3.1%+0.9%-2.9%
30D-8.0%-0.9%-7.1%-8.1%
3M-12.9%-4.2%-8.7%-13.1%
6M-21.1%-1.6%-19.5%-21.0%
All-21.1%-0.7%-20.4%-21.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling